iFlytek's Subsidiary Xunfei Healthcare Technologies Lists on HKEX, Raises Over HKD 580 Million

iFlytek’s Subsidiary Xunfei Healthcare Technologies Lists on HKEX, Raises Over HKD 580 Million

Xunfei Healthcare Technology Co., Ltd, a subsidiary of China-based information technology company iFlytek Co., Ltd (SHE: 002230), has officially launched its initial public offering (IPO) on the Hong Kong Stock Exchange. The company issued 7,035,550 shares at a price of HKD 82.8 per share, securing over HKD 580 million (USD 74.63 million) in the process.

AI-Driven Medical Solutions Provider Enters Capital Markets
Xunfei Healthcare, known for its artificial intelligence (AI)-empowered medical solutions, has a comprehensive product portfolio that addresses various stages of healthcare. The company’s offerings include health risk warning, early screening, auxiliary diagnosis and treatment, treatment effectiveness evaluation, post-diagnosis management, and chronic disease management. This IPO marks a significant milestone for Xunfei Healthcare as it expands its reach and impact within the healthcare sector.

Implications for the Healthcare Industry
The successful IPO of Xunfei Healthcare Technology Co., Ltd highlights the growing interest and investment in AI-driven healthcare solutions. As the company enters the capital markets, it is poised to leverage the funds raised to further develop its AI technologies and enhance its service offerings, potentially transforming the healthcare industry through innovative medical solutions.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry